Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 0

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 0
---
TABLE OF CONTENTS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14(C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box:

| ☐ | Preliminary Information Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) |

| ☒ | Definitive Information Statement |

CHANNEL THERAPEUTICS CORPORATION (Name of Registrant As Specified In Its Charter) Payment of Filing Fee (Check the appropriate box):

| ☐ | No fee required |

| ☒ | Fee paid previously with preliminary materials |

| ☐ | Fee computed on table in exhibit required by Item 25(b) of Schedule 14A (17 CFR 240.14a-101) per Item 1 of this Schedule and Exchange Act Rules 14c-5(g) and 0-11 |

#### TABLE OF CONTENTS

### CHANNEL THERAPEUTICS CORPORATION

#### 4400 Route 9 South, Suite 1000

#### Freehold, NJ 07728

### NOTICE OF ACTION BY WRITTEN CONSENT AND INFORMATION STATEMENT

### WE ARE NOT ASKING YOU FOR A PROXY AND

#### YOU ARE REQUESTED NOT TO SEND US A PROXY.
To Our Stockholders:

This notice of action by written consent and the accompanying information statement is being furnished by the Board of Directors of Channel Therapeutics Corporation, a Nevada corporation (“Channel”, “we”, “us” or “our”), to the holders of record at the close of business on April 23, 2025 of the outstanding shares of the Channel’s common stock, par value $0.0001 per share (“Channel common stock”), pursuant to Rule 14c-2 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in connection with an Agreement and Plan of Merger (the “Merger Agreement”), dated April 16, 2025, pursuant to which, subject to the terms and conditions thereof, CHRO Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Channel (the “Merger Sub”), will merge with and into LNHC, Inc., a Delaware corporation (“LNHC”), with LNHC surviving as a wholly owned subsidiary of Channel, and the surviving corporation of the merger, which transaction is